Skip to search formSkip to main contentSkip to account menu

afoxolaner 136 MG Chewable Tablet [NexGard]

Known as: NexGard 136 MG Chewable Tablet, afoxolaner 136 mg ORAL TABLET, CHEWABLE [NexGard] 
National Institutes of Health

Related topics

Related topics

3 relations
Chewable TabletNexGardafoxolaner

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Efficacy of a Single Oral Administration of Afoxolaner Alone or in Combination with Milbemycin Oxime against Ixodes hexagonus Ticks in Dogs
The efficacy of afoxolaner (NexGard® and NexGard Spectra®, Boehringer-Ingelheim), administered once orally at the minimum… 
2016
2016
bility of an oral formulation of afoxolaner to protect dogs from orrelia burgdorferi infection transmitted by wild Ixodes scapularis icks
A randomized, blinded, negative controlled study was conducted to determine whether treatment with afoxolaner (NexGard®, Merial… 
2016
2016
Efficacy against nematode infections and safety of afoxolaner plus milbemycin oxime chewable tablets in domestic dogs under field conditions in Europe
Afoxolaner (AFX) plus milbemycin oxime (MO) combination chewable tablets (NexGard Spectra®, Merial) were evaluated for safety and… 
2016
2016
Efficacy of oral afoxolaner plus milbemycin oxime chewables against induced infestations with Dermacentor reticulatus in dogs
The efficacy of afoxolaner plus milbemycin oxime (AFX + MO) combination chewables (NexGard Spectra®, Merial) and AFX single… 
2015
2015
Comparative Efficacy of an Imidacloprid/Flumethrin Collar (Seresto®) and an Oral Afoxolaner Chewable (NexGard®) against Tick (Dermacentor variabilis and Amblyomma americanum) Infestations on Dogs: a…
This randomised controlled laboratory study demonstrated the residual speed of efficacy of an imidacloprid/flumethrin collar…